CRP and Kawasaki disease: C-reactive protein (CRP) may further enhance the localised deposition of complement in the vessel wall, since gross elevation of CRP occurs in the acute phase of Kawasaki disease (and COVID-19) and this protein can mediate classical pathway activation of complement (26, 27).